Table 4.
Results of the Cox proportional hazard analysis
| Clinical or imaging feature |
Imaging evolution |
Alert findings |
||||
| HR | P value | 95%CI | HR | P value | 95%CI | |
| Sex | 0.78 | 0.569 | 0.33-1.81 | 0.60 | 0.644 | 0.69-5.19 |
| Age | 0.98 | 0.488 | 0.95-1.02 | 1.00 | 0.967 | 0.92-1.08 |
| Previous cholecistectomy | 0.89 | 0.794 | 0.40-2.00 | -1 | ||
| Diabetes mellitus (type 2) | 0.92 | 0.873 | 0.34-2.44 | 2.39 | 0.316 | 0.43-13.14 |
| Autoimmune systemic disease | 0.58 | 0.218 | 0.25-1.36 | 0.51 | 0.543 | 0.59-4.39 |
| Alcoholic liver cirrhosis | 1.88 | 0.143 | 0.80-4.40 | 2.49 | 0.295 | 0.45-13.75 |
| History of extrapancreatic neoplasia | 1.79 | 0.109 | 0.87-3.68 | 0.70 | 0.694 | 0.12-3.93 |
| Cysts size > 10 mm on baseline MRCP | 2.13 | 0.055 | 0.98-4.64 | 4.02 | 0.205 | 0.46-34.70 |
| Number of cysts on baseline MRCP | 1.42 | 0.590 | 0.70-1.96 | 1.26 | 0.680 | 0.40-3.95 |
No patients showing the outcome. MRCP: Magnetic resonance cholangiopancreatography.